- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03601377
Attention Bias Modification Treatment in Social Anxiety (ABMT)
Attention Bias Modification Treatment in Social Anxiety: Avoidance or Exposure to Threatening Faces? The Role of Pre-existing Attentional Biases and State Anxiety
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Social anxiety is a highly prevalent disorder in the population. Even though there are effective interventions that can help people who suffer from it, many of them do not seek or receive an evidence-based, face to face treatment. According to cognitive models, attention to social threat is one of the principles that maintain social anxiety. In fact, individuals with social anxiety present attention bias to threat stimuli. However, there is inconsistency in the literature with regards to attentional biases that individuals with anxiety present. A recent model is the vigilance-avoidance hypothesis, in which socially anxious initially focus on the threat and then they avoid it. Therefore, better understanding and then aiming to modify these attentional biases in a computerized manner, with minimal therapist interaction can be a novel and promising way to treat social anxiety, even among patients who avoid presenting for therapy.
Two experiments are aiming to shed some light with regards to the effect of attention bias modification treatment in individuals with social anxiety, taking into consideration the previous mixed results. The first experiment compares training attention to be directed away from threat with a placebo treatment. Approximately 60 socially anxious individuals are randomly allocated in the 2 groups. A structured interview and self-report assessment are done pre-treatment, post-treatment and 6 months follow-up.
The second experiment adds a third group of training towards threat (i.e. exposure), investigating if changing attentional avoidance can also affect anxiety levels. Moreover, the second experiment attempts to improve the typical attention modification paradigm by targeting treatment to participants' identified pre-experimental attentional biases. In addition, predictors of treatment effectiveness will be studied and particularly pre-intervention attentional biases as well as state anxiety. Participants are approximately 90 adults with social phobia who are randomly allocated in treatment and placebo groups. In experiment 2 participants will also be assessed behaviourally as well as physiologically to better demonstrate that anxiety reactions to anxiogenic situations have been reduced between pre and post treatment and that they are smaller than those of a placebo control group.
It is expected that participants in the intervention groups will show reduced attentional bias and social anxiety symptoms in comparison with the placebo group in both studies. In addition, the kind of pre-intervention bias as well as state anxiety will moderate anxiety changes. This study will enrich existing research on attention bias modification treatment by shedding light into potential mechanisms of change and will examine ways to improve the efficacy of this intervention.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nicosia, Cyprus, 1678
- Department of Psychology, University of Cyprus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
1) highly socially anxious students (based on self-report questionnaire)
Exclusion Criteria:
- suicidal intent,
- substance abuse,
- primary diagnosis of post-traumatic stress disorder, obsessive-compulsive disorder,
- or past schizophrenia, bipolar disorder, organic mental disorder,
- any concurrent psychotherapy,
- changes in medication during the 12 weeks prior to study and
- CBT therapy 6 months before the beginning of treatment.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Training away from threat
Experiment 1 and 2: In the intervention group -training away from threat-, in all angry-neutral faces presentation the probe is presented only after neutral face. Probe type (< or >) is not factorially counterbalanced but there is equal possibility of presentation for each of the following: angry-face location, probe location, or actor. Experiment 1: received 8 times (2 times per week for 4 weeks) Experiment 2: received 4 times (2 times for 2 weeks) |
Dot-probe task: Pairs of stimuli, angry - neutral face or neutral - neutral faces of the same actor (20 different individuals;10 male, 10 female) are presented horizontally in the centre of the screen (160 trials; 120 angry-neutral and 40 neutral-neutral).
Each trial begins with a fixation cross (500 ms), on which the participants are instructed to focus their gaze.
After that a pair of faces follows which is presented on the screen for 500ms.
After the faces presentation a small visual probe (< or >) appears at the same place of one of the two faces.
Participants have to determine which symbol appeared by clicking right or left on the mouse as quickly as possible.
The target probe remains on the screen until there is a response, which starts a new trial.
|
Experimental: Training towards threat
Only for Experiment 2: The second ABMT condition -training towards threat- is identical to the first one with the exception that in all angry-neutral face presentations the symbol is presented only after threat face. In addition, at the beginning of every session participants will be informed that a random number of participants will have to repeat their speech. They will also be informed that this instruction will be given right after the dot probe task completion. This will be done in order for the participants to maintain their state anxiety but repetition of the speech task will not actually happen at this stage. Experiment 2: received 4 times (2 times for 2 weeks) |
Dot-probe task: Pairs of stimuli, angry - neutral face or neutral - neutral faces of the same actor (20 different individuals;10 male, 10 female) are presented horizontally in the centre of the screen (160 trials; 120 angry-neutral and 40 neutral-neutral).
Each trial begins with a fixation cross (500 ms), on which the participants are instructed to focus their gaze.
After that a pair of faces follows which is presented on the screen for 500ms.
After the faces presentation a small visual probe (< or >) appears at the same place of one of the two faces.
Participants have to determine which symbol appeared by clicking right or left on the mouse as quickly as possible.
The target probe remains on the screen until there is a response, which starts a new trial.
|
Placebo Comparator: Placebo
Experiment 1 and 2: In the placebo group, angry-face location, probe location and actor are fully counterbalanced with regards to their presentation. Experiment 1: received 8 times (2 times per week for 4 weeks) Experiment 2: received 4 times (2 times for 2 weeks) |
Dot-probe task: Pairs of stimuli, angry - neutral face or neutral - neutral faces of the same actor (20 different individuals;10 male, 10 female) are presented horizontally in the centre of the screen (160 trials; 120 angry-neutral and 40 neutral-neutral).
Each trial begins with a fixation cross (500 ms), on which the participants are instructed to focus their gaze.
After that a pair of faces follows which is presented on the screen for 500ms.
After the faces presentation a small visual probe (< or >) appears at the same place of one of the two faces.
Participants have to determine which symbol appeared by clicking right or left on the mouse as quickly as possible.
The target probe remains on the screen until there is a response, which starts a new trial.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Social Anxiety levels
Time Frame: Pre-treatment (day 1)
|
Experiment 1 & 2: self-reported questionnaires, with the primary one to be Social Phobia and Anxiety Inventory-23.
|
Pre-treatment (day 1)
|
Social Anxiety changes
Time Frame: Experiment 1: 4 weeks after the day 1, Experiment 2: 3 weeks after the day 1 (Post-treatment)
|
Experiment 1 & 2: Measured in self-reported questionnaires with the primary one to be Social Phobia and Anxiety Inventory-23.
|
Experiment 1: 4 weeks after the day 1, Experiment 2: 3 weeks after the day 1 (Post-treatment)
|
Social Anxiety changes
Time Frame: 6 months after day 1 (Follow-up)
|
Only for experiment 1: Measured in self-reported questionnaires with the primary one to be Social Phobia and Anxiety Inventory-23.
|
6 months after day 1 (Follow-up)
|
Attentional Biases
Time Frame: Pre-treatment (day 1)
|
For experiment 1: Assess kind of attentional biases using the dot-probe task (comparison of reaction time to threatening and a neutral stimulus). For experiment 2: Assess kind of attentional biases using the eye-tracking task (measuring eye gaze). |
Pre-treatment (day 1)
|
Attentional Biases changes
Time Frame: 4 weeks after the day 1 (Post-treatment)
|
For experiment 1: Assess kind of attentional biases using the dot-probe task (comparison of reaction time to threatening and a neutral stimulus). For experiment 2: Assess kind of attentional biases using the eye-tracking task (measuring eye gaze). |
4 weeks after the day 1 (Post-treatment)
|
Attentional Biases changes
Time Frame: 6 months after day 1 (Follow-up)
|
Only for experiment 1: Assess kind of attentional biases using the dot-probe task (comparison of reaction time to threatening and a neutral stimulus).
|
6 months after day 1 (Follow-up)
|
Physical social anxiety levels
Time Frame: Pre-treatment (day 1)
|
Only for experiment 2: measured through physiological measures, with the primary one to be heart rate.
|
Pre-treatment (day 1)
|
Physical social anxiety changes
Time Frame: 3 weeks after the day 1 (Post-treatment)
|
Only for experiment 2: measured through physiological measures, with the primary one to be heart rate.
|
3 weeks after the day 1 (Post-treatment)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Social Anxiety levels (clinical interview)
Time Frame: Pre-treatment (day 1)
|
Experiment 1 & 2: measured through clinical interview, Anxiety Disorders Interview Schedule (ADIS) adult version.
|
Pre-treatment (day 1)
|
Physical social anxiety levels 1
Time Frame: Pre-treatment (day 1)
|
Only for experiment 2: measured through skin conductance
|
Pre-treatment (day 1)
|
Physical social anxiety levels 2
Time Frame: Pre-treatment (day 1)
|
Only for experiment 2: measured through corrugator supercilii
|
Pre-treatment (day 1)
|
Social anxiety changes
Time Frame: 4 weeks after the day 1 (Post-treatment)
|
Experiment 1: measured through clinical interview, Anxiety Disorders Interview Schedule (ADIS) adult version.
|
4 weeks after the day 1 (Post-treatment)
|
Physical social anxiety changes 1
Time Frame: 3 weeks after the day 1 (Post-treatment)
|
Only for experiment 2: measured through skin conductance
|
3 weeks after the day 1 (Post-treatment)
|
Social anxiety changes
Time Frame: 6 months after day 1 (follow-up)
|
Experiment 1: measured through clinical interview, Anxiety Disorders Interview Schedule (ADIS) adult version.
|
6 months after day 1 (follow-up)
|
Physical social anxiety changes 2
Time Frame: 3 weeks after the day 1 (Post-treatment)
|
Only for experiment 2: measured through corrugator supercilii
|
3 weeks after the day 1 (Post-treatment)
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Georgia Panayiotou, PhD, Associate Prof., Department of Psychology, University of Cyprus
Publications and helpful links
General Publications
- Bar-Haim Y. Research review: Attention bias modification (ABM): a novel treatment for anxiety disorders. J Child Psychol Psychiatry. 2010 Aug;51(8):859-70. doi: 10.1111/j.1469-7610.2010.02251.x. Epub 2010 May 6.
- Amir N, Beard C, Taylor CT, Klumpp H, Elias J, Burns M, Chen X. Attention training in individuals with generalized social phobia: A randomized controlled trial. J Consult Clin Psychol. 2009 Oct;77(5):961-973. doi: 10.1037/a0016685.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ABMT University of Cyprus
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Social Anxiety
-
Aya Technologies LimitedCompletedSocial Anxiety | Social Anxiety Disorder | Social Anxiety Disorder (Social Phobia)United Kingdom
-
Tel Aviv UniversityCompletedSocial Anxiety | Social Anxiety Disorder | Social Anxiety Disorder (Social Phobia)Israel
-
University of ManchesterManchester University NHS Foundation TrustCompletedSocial Anxiety | Social Anxiety Disorder | Social PhobiaUnited Kingdom
-
Aya Technologies LimitedCompletedSocial Anxiety | Social Anxiety Disorder | Social Anxiety Disorder (Social Phobia)United Kingdom
-
University of BernUniversity of LuebeckActive, not recruitingSocial Anxiety Disorder (Social Phobia)Switzerland
-
University of BernActive, not recruitingSocial Anxiety | Social Anxiety DisorderSwitzerland
-
University of Wisconsin, MilwaukeeTerminatedSocial Anxiety | Social Anxiety DisorderUnited States
-
Weill Medical College of Cornell UniversityBrain & Behavior Research FoundationTerminatedSocial Anxiety | Social Anxiety Disorder | Social Anxiety Disorder of ChildhoodUnited States
-
Stockholm UniversityPBM; MimerseCompletedSocial Anxiety | Public Speaking | Social Anxiety Disorder, Performance OnlySweden
-
Tufts UniversityCompletedSocial Anxiety | Social Anxiety Disorder | Social Anxiety Disorder of ChildhoodUnited States
Clinical Trials on Training away from threat
-
First Affiliated Hospital of Jinan UniversityUnknownGastroesophageal Reflux | Bariatric SurgeryChina
-
University of TorontoUnknown
-
University of Texas at AustinTerminated
-
Shanghai Proton and Heavy Ion CenterTerminatedHepatocellular CarcinomaChina
-
Washington State UniversityUnknownSubstance Abuse | Risk Reduction | RIsky Sexual BehaviorUnited States
-
Universidad Miguel Hernandez de ElcheHospital Universitario San Juan de AlicanteUnknown
-
University of California, San FranciscoUnited States Department of Defense; San Francisco Veterans Affairs Medical...CompletedAlcohol Use Disorder | Post-Traumatic Stress DisorderUnited States
-
i4HealthCompletedPostpartum DepressionUnited States
-
Vanderbilt University Medical CenterNational Institute of Allergy and Infectious Diseases (NIAID); University of...Completed
-
University of Alabama at BirminghamRecruiting